Senior Management
Dr Owain Millington
CHIEF EXECUTIVE OFFICER
Julie Bailey
CHIEF FINANCIAL OFFICER
CHIEF EXECUTIVE OFFICER
CHIEF FINANCIAL OFFICER
CHIEF FINANCIAL OFFICER
Julie is a certified and chartered accountant who has worked for over two decades in executive finance roles. Prior to joining ILC, Julie has served in CFO and MD roles, with oversight of finance, HR, sales & marketing and IT. In addition, she co-founded a health supplement e-commerce (exited 2023) and Turnkey, a venture partner studio providing services for equity in start-up/spin-outs. She has led multiple successful raises and exits and provides financial clarity for effective decision-making in fast-paced corporate environments.
CHIEF OPERATING OFFICER
Dawn has around 15 years of experience in the drug development space. Managing and coordinating the phases of the drug development process, from lead discovery, to PoC, CMC, GLP toxicology and safety pharmacology, clinical trials (FIM & Ph IIa), as well as directing regulatory, quality and funding oversite. Dawn has held key roles in early-stage biotech, including MGB Biopharma and EnteroBiotix. She has wide experience in programme management with third parties, consultants and KOLs to support new therapeutics to the clinic.
CHIEF EXECUTIVE OFFICER
Owain has 20 years' experience in the immunology space. Having led an independent academic research group investigating immunity in the context of infectious and inflammatory diseases, Owain moved into biotech in 2017. Since then, he has worked in early-stage companies, including TC BioPharm, Medisix and Matterhorn Biosciences. He has strong experience in building and leading Discovery and Development teams, successfully identifying new candidates and delivering immunotherapy products into the clinic.